(Bloomberg) — Eli Lilly agreed to buy Waltham-based gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some ...
Federal filings showed no companies other than Lilly made an offer to buy Morphic, while Novartis executives said they’re still waiting for more data on pelabresib.
Eli Lilly LLY-0.60%decrease; red down pointing triangle has agreed to buy biopharmaceutical company Morphic Holding MORF 0.02%increase; green up pointing triangle for $3.2 billion in a deal ...
Eli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a once-daily formulation of danuglipron for further development as a weight loss pill. Is Eli ...